文献速递神经介入DSA

颅内动脉粥样硬化性狭窄患者血栓切除术后急诊血管成形术和/或支架置入

Angioplasty and/or stenting after thrombectomy in patients with underlying intracranial atherosclerotic stenosis.
PubMed 文献 · Neuroradiology · 2019-07-29

这项多中心前瞻性队列研究纳入113例前循环闭塞且潜在ICAS>70%的ELVO患者,其中81例(71.7%)在机械取栓后接受急诊血管成形术和/或支架置入。该组24小时再通率显著更高(aOR 3.782,95%CI 1.821-9.125,P=0.02),早期神经功能恶化更少(aOR 0.299,95%CI 0.110-0.821,P=0.01),症状性颅内出血、无症状性颅内出血、90天死亡和90天功能独立无显著差异。结论认为该操作可行,可能降低再闭塞和早期神经功能恶化风险,且不增加出血和死亡风险。

要点

  • 对于取栓后存在潜在重度ICAS的ELVO患者,急诊血管成形术和/或支架置入与24小时再通率更高相关(aOR 3.782)。
  • 该操作与早期神经功能恶化风险更低相关(aOR 0.299),症状性颅内出血和死亡风险未显著增加。
  • 90天功能独立在两组间无显著差异(aOR 1.752,95%CI 0.774-3.257,P=0.16)。

核心结论

  • 在ELVO合并潜在ICAS患者中,急诊血管成形术和/或支架置入可能降低再闭塞和早期神经功能恶化风险,且不增加颅内出血和死亡风险。

研究设计与样本

  • 多中心前瞻性队列研究,纳入113例前循环潜在ICAS>70%的ELVO患者,81例(71.7%)接受急诊血管成形术和/或支架置入,其余未接受,主要结局为24小时再通率(改良动脉闭塞病变评分2或3分)。

诊断标准与关键数值

  • 主要结局24小时再通定义为改良动脉闭塞病变评分2或3分;潜在ICAS定义为狭窄>70%;急诊血管成形术和/或支架置入组24小时再通aOR 3.782(95%CI 1.821-9.125,P=0.02),早期神经功能恶化aOR 0.299(95%CI 0.110-0.821,P=0.01),症状性颅内出血aOR 0.710(95%CI 0.199-2.622,P=0.67),无症状性颅内出血aOR 1.325(95%CI 0.567-3.031,P=0.81),90天死亡aOR 0.581(95%CI 0.186-2.314,P=0.41),90天功能独立aOR 1.752(95%CI 0.774-3.257,P=0.16),均与未接受组比较。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To investigate the imaging and clinical outcomes of emergent angioplasty and/or stenting or neither in patients of emergent large-vessel occlusion (ELVO) with underlying severe intracranial atherosclerotic stenosis (ICAS).

METHODS: In this multicenter prospective cohort study, we included patients of ELVO with underlying ICAS. Patients received emergent angioplasty and/or stenting or neither after mechanical thrombectomy at the interventionists' discretion. The primary outcome was recanalization rate at 24 h, which was defined as a modified arterial occlusive lesion score of 2 or 3.

RESULTS: A total of 113 consecutive patients with underlying ICAS > 70% in anterior cerebral circulation were enrolled in this study. Of these, 81 (71.7%) received emergent angioplasty and/or stenting after thrombectomy. Patients in the emergent angioplasty and/or stenting group were significantly more likely to have recanalization at 24 h (adjusted OR [aOR], 3.782; 95% confidence interval [CI], 1.821-9.125; P = 0.02) and less likely to have early neurologic deterioration (aOR, 0.299; 95% CI, 0.110-0.821; P = 0.01). However, emergent angioplasty and/or stenting was not significantly associated with symptomatic intracranial hemorrhage (aOR, 0.710; 95% CI, 0.199-2.622; P = 0.67), asymptomatic intracranial hemorrhage (aOR, 1.325; 95% CI, 0.567-3.031; P = 0.81), death at 90 days (aOR, 0.581; 95% CI, 0.186-2.314; P = 0.41), and functional independence at 90 days (aOR, 1.752; 95% CI, 0.774-3.257; P = 0.16), compared with patients that received neither.

CONCLUSION: Emergent angioplasty and/or stenting is possible in patients of ELVO with ICAS and may reduce the risk of reocclusion and early neurologic deterioration with no increased risk of intracranial hemorrhage and death than those received neither.

来源:Neuroradiology,查看原文。版权归原作者所有。

引用

  1. Wu C, Chang W, Wu D, et al. Angioplasty and/or stenting after thrombectomy in patients with underlying intracranial atherosclerotic stenosis. Neuroradiology. 2019. PMID: 31353425. doi:10.1007/s00234-019-02262-5

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。